TY - JOUR T1 - Why Targeting PSMA is a valuable addition in the management of castration-resistant prostate cancer: The Urologists' point of view JF - Journal of Nuclear Medicine JO - J Nucl Med DO - 10.2967/jnumed.117.194753 SP - jnumed.117.194753 AU - Boris Hadaschik AU - Martin Boegemann Y1 - 2017/05/01 UR - http://jnm.snmjournals.org/content/early/2017/05/17/jnumed.117.194753.abstract N2 - 300 Multiple ChoicesThis is a pdf-only article and there is no markup to show you.full-text.pdf ER -